Vickery Trinkaus-Randall

Dr. Vickery Trinkaus-Randall

orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
XGXiaoqing Guo
Xiaoqing Guo
AHAudrey E. K. Hutcheon
Audrey E. K. Hutcheon
SMSuzanna A. Melotti
Suzanna A. Melotti
JZJames Zieske
James Zieske
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall
JRJeffrey W. Ruberti
Jeffrey W. Ruberti
Purpose. To characterize the structure and morphology of extracellular matrix (ECM) synthesized by untransformed, cultured human corneal fibroblasts in long-term cultures. methods. Human corneal stromal keratocytes were expanded in transwell culture in the presence of fetal bovine serum and a stable derivative of vitamin C. The cells were allowed to synthesize a fibrillar ECM for up to 5 weeks. Constructs were assessed by light (phase-contrast and differential interference-contrast) and transmission (standard and quick freeze/deep etch) microscopy. results. Electron micrographs revealed stratified constructs with multiple parallel layers of cells and an extracellular matrix comprising parallel arrays of small, polydisperse fibrils (27–51 nm) that often alternate in direction. Differential interference contrast images demonstrated oriented ECM fibril arrays parallel to the plane of the construct, whereas quick-freeze, deep-etch micrographs showed the details of the matrix interaction with fibroblasts through arrays of membrane surface structures. conclusions. Human keratocytes, cultured in a stable vitamin C derivative, are capable of assembling extracellular matrix, which comprises parallel arrays of ECM fibrils. The resultant constructs, which are highly cellular, are morphologically similar to the developing mammalian stroma, where organized matrix is derived. The appearance of arrays of structures on the cell membranes suggests a role in the local organization of synthesized ECM. This model could provide critical insight into the fundamental processes that govern the genesis of organized connective tissues such as the cornea and may provide a scaffolding suitable for tissue engineering a biomimetic stroma.

1 April 2014 in Experimental Eye Research
Verified
Journal Article
Closed access
Mary Ann SteppMary Ann Stepp
Mary Ann Stepp
JZJames Zieske
James Zieske
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall
BKBriana M. Kyne
Briana M. Kyne
SPSonali Pal-Ghosh
Sonali Pal-Ghosh
APAhdeah Pajoohesh-Ganji
Ahdeah Pajoohesh-Ganji

15 December 2011 in Blood
Verified
Journal Article
Closed access
JWJennifer Ellis Ward
Jennifer Ellis Ward
RRRuiyi Ren
Ruiyi Ren
GTGianluca Toraldo
Gianluca Toraldo
PSPam SooHoo
Pam SooHoo
JGJian Guan
Jian Guan
DSDavid C. Seldin
David C. Seldin
Systemic AL amyloidosis results from the aggregation of an amyloidogenic immunoglobulin (Ig) light chain (LC) usually produced by a plasma cell clone in the bone marrow. AL is the most rapidly fatal of the systemic amyloidoses, as amyloid fibrils can rapidly accumulate in tissues including the heart, kidneys, autonomic or peripheral nervous systems, gastrointestinal tract, and liver. Chemotherapy is used to eradicate the cellular source of the amyloidogenic precursor. Currently, there are no therapies that target the process of LC aggregation, fibril formation, or organ damage. We developed transgenic mice expressing an amyloidogenic λ6 LC using the cytomegalovirus (CMV) promoter to circumvent the disruption of B cell development by premature expression of recombined LC. The CMV-λ6 transgenic mice develop neurologic dysfunction and Congophilic amyloid deposits in the stomach. Amyloid deposition was inhibited in vivo by the antibiotic doxycycline. In vitro studies demonstrated that doxycycline directly disrupted the formation of recombinant LC fibrils. Furthermore, treatment of ex vivo LC amyloid fibrils with doxycycline reduced the number of intact fibrils and led to the formation of large disordered aggregates. The CMV-λ6 transgenic model replicates the process of AL amyloidosis and is useful for testing the antifibril potential of orally available agents.

1 December 2001 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
VKVeronica E. Klepeis
Veronica E. Klepeis
ACAnn Cornell-Bell
Ann Cornell-Bell
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall
This paper characterizes the early responses of epithelial cells to injury. Ca2+ is an important early messenger that transiently increases in the cytoplasm of cells in response to external stimuli. Its elevation leads to the regulation of signaling pathways responsible for the downstream events important for wound repair, such as cell migration and proliferation. Live cell imaging in combination with confocal laser scanning microscopy of fluo-3 AM loaded cells was performed. We found that mechanical injury in a confluent region of cells creates an elevation in Ca2+ that is immediately initiated at the wound edge and travels as a wave to neighboring cells, with [Ca2+]i returning to background levels within two minutes. Addition of epidermal growth factor (EGF), but not platelet-derived growth factor-BB, resulted in increased [Ca2+]i, and EGF specifically enhanced the amplitude and duration of the injury-induced Ca2+ wave. Propagation of the Ca2+ wave was dependent on intracellular Ca2+ stores, as was demonstrated using both thapsigargin and Ca2+ chelators (EGTA and BAPTA/AM). Injury-induced Ca2+ waves were not mediated via gap junctions, as the gap-junction inhibitors 1-heptanol and 18α-glycyrrhetinic acid did not alter wave propagation, nor did the cells recover in photobleaching experiments. Additional studies also demonstrated that the wave could propagate across an acellular region. The propagation of the injury-induced Ca2+ wave occurs via diffusion of an extracellular mediator, most probably via a nucleotide such as ATP or UTP, that is released upon cell damage.Movies available on-line

24 September 2004 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
VKVeronica E. Klepeis
Veronica E. Klepeis
IWIlene Weinger
Ilene Weinger
EKElzbieta Kaczmarek
Elzbieta Kaczmarek
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall

1 June 2001 in Journal of Molecular Biology
Verified
Journal Article
Closed access
SSSandhya Sanghi
Sandhya Sanghi
RKRajesh Kumar
Rajesh Kumar
ALAngela Lumsden
Angela Lumsden
DDDouglas Dickinson
Douglas Dickinson
VKVeronica Klepeis
Veronica Klepeis
GLGordon Laurie
Gordon Laurie